IL1R1 — Drug Target
All drugs that target IL1R1 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- AMG 301 · Amgen · IL-1 receptor antagonist · Oncology
AMG 301 is a monoclonal antibody targeting the interleukin-1 receptor type 1 (IL1R1).